A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Incyte Corporation
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Pfizer
Prescient Therapeutics, Ltd.
iOnctura
Wake Forest University Health Sciences
Children's Oncology Group
Essen Biotech
St. Jude Children's Research Hospital
City of Hope Medical Center
Seagen Inc.
OncoNano Medicine, Inc.
Columbia University
National Cancer Institute (NCI)
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Arcus Biosciences, Inc.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
Tianjin Medical University Cancer Institute and Hospital
Kymera Therapeutics, Inc.
GlaxoSmithKline
Cedars-Sinai Medical Center
Daiichi Sankyo
Checkpoint Therapeutics, Inc.
Taproot Health
Columbia University
National Cancer Institute (NCI)
City of Hope Medical Center
Celldex Therapeutics
Stanford University
Stanford University
Peking University First Hospital
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
Children's Oncology Group
University of Nebraska
Eastern Cooperative Oncology Group
Stanford University
Seagen Inc.
Bristol-Myers Squibb
Atara Biotherapeutics